PuSH - Publikationsserver des Helmholtz Zentrums München

129 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Buitinga, M.* et al.: Non-invasive monitoring of glycemia-induced regulation of GLP-1R expression in murine and human islets of Langerhans. Diabetes 69, 2246-2252 (2020)
2.
Elhadad, M.A. et al.: Deciphering the plasma proteome of type 2 diabetes. Diabetes 69, 2766-2778 (2020)
3.
Huang, J. et al.: Machine learning approaches reveal metabolic signatures of incident chronic kidney disease in individuals with prediabetes and type 2 diabetes. Diabetes 69, 2756-2765 (2020)
4.
Jende, J.M.E.* et al.: Troponin T parallels structural nerve damage in type 2 diabetes: A cross-sectional study using magnetic resonance neurography. Diabetes 69, 713-723 (2020)
5.
Kleinert, M. & Müller, T.D.: A new FGF21 analog for the treatment of fatty liver disease. Diabetes 69, 1605-1607 (2020)
6.
Knopp, J. et al.: Maternal type 1 diabetes reduces autoantigen-responsive CD4(+) T cells in Offspring. Diabetes 69, 661-669 (2020)
7.
Li, Q.* et al.: Longitudinal metabolome-wide signals prior to the appearance of a first islet autoantibody in children participating in the TEDDY Study. Diabetes 69, 465-476 (2020)
8.
Rubey, M. et al.: DLL1- and DLL4-mediated notch signaling is essential for adult pancreatic islet homeostasis. Diabetes 69, 915-926 (2020)
9.
Graae, A.S.* et al.: ADAMTS9 regulates skeletal muscle insulin sensitivity through extracellular matrix alterations. Diabetes 68, 502-514 (2019)
10.
Groener, J.B.* et al.: Understanding diabetic neuropathy: From subclinical nerve lesions to severe nerve fiber deficits. A cross-sectional study in patients with type 2 diabetes and healthy controls. Diabetes, accepted (2019)
11.
Herrera Moro Chao, D.* et al.: The iminosugar AMP-DNM improves satiety and activates brown adipose tissue through GLP1. Diabetes 68, 2223-2234 (2019)
12.
Hippich, M. et al.: Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families. Diabetes 68, 847-857 (2019)
13.
Ji, Y.* et al.: Genome-wide and abdominal MRI data provide evidence that a genetically determined favorable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease, and hypertension. Diabetes 68, 207-219 (2019)
14.
Ma, J.* et al.: A peripheral blood DNA methylation signature of hepatic fat reveals a potential causal pathway for non-alcoholic fatty liver disease. Diabetes 68, 1073-1083 (2019)
15.
Ratner, C.* et al.: Long-acting neurotensin synergizes with liraglutide to reverse obesity through a melanocortin-dependent pathway. Diabetes 68, 1329-1340 (2019)
16.
Wittenbecher, C.* et al.: Insulin-like growth factor binding protein 2 (IGFBP-2) and the risk of developing type 2 diabetes. Diabetes 68, 188-197 (2019)
17.
Endesfelder, D. et al.: Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children. Diabetes 68, 119-130 (2018)
18.
Herder, C.* et al.: A systemic inflammatory signature reflecting crosstalk between innate and adaptive immunity is associated with polyneuropathy: KORA F4/FF4 Study. Diabetes 67, 2434-2442 (2018)
19.
Kim, T.* et al.: Glucagon receptor signaling regulates energy metabolism via hepatic farnesoid X receptor and fibroblast growth factor 21. Diabetes 67, 1773-1782 (2018)
20.
Kroeger, J.* et al.: Circulating fetuin - A and risk of type 2 diabetes : A mendelian randomization analysis. Diabetes 67, 1200-1205 (2018)